Daniel Faga

CIK 1673528 · President, CEO · last filed 2026-05-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$28.36M

Companies

4

Total Filings

35

Lifetime Open-Market Net

-$9.41M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRAX President, CEO 496,684 $0 2 2026-05-14
ANAB President, CEO 505,862 $56.07 $28.36M -$6.34M 15 2026-04-23
Mirati Therapeutics, Inc. (MRTX) Delisted EVP, Chief Operating Officer 30,638 $58.70 $1.80M -$828.3K 4 2021-02-03
Spark Therapeutics, Inc. (ONCE) Delisted Chief Business Officer 0 -$2.23M 14 2019-12-17

Recent Filings · Page 4 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-07-26 Spark Therapeutics, Inc. (ONCE) Delisted Mixed -$97.1K EDGAR
2017-06-29 Spark Therapeutics, Inc. (ONCE) Delisted Mixed -$112.9K EDGAR
2017-05-17 Spark Therapeutics, Inc. (ONCE) Delisted Mixed -$86.8K EDGAR
2017-01-20 Spark Therapeutics, Inc. (ONCE) Delisted Grant (A) $0 EDGAR
2016-05-04 Spark Therapeutics, Inc. (ONCE) Delisted Grant (A) $0 EDGAR
Showing 3135 of 35
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.